We are an iconic provider of hospital-based healthcare, striving to deliver an exceptional standard of care
We comprise several hospitals, health centres, a nationally accredited education provider and a world-class research institute
We are a nationally accredited, hospital-based Registered Training Organisation - the only one of its kind in Queensland
We are part of a collaborative research institute with The University of Queensland and founding partner of the Translational Research Institute
Health . Education . Research . Foundation
Queensland Scientists have discovered a possible link between Parkinson’s disease and a gene impacted by a neurotoxin found in blue-green algae.
Cognitive Health Genomics Group Leader Dr Jacob Gratten from Mater Research said the findings increased the understanding of the environmental risk factors of Parkinson’s disease.
“We looked for a link between Parkinson’s and changes in the human genome that control how genes are turned on and off, because these changes can be influenced by the environment,” Dr Gratten said.
“We found a gene, previously not known to be linked to Parkinson’s, which displayed reduced activity in people with the disease.
“This same gene is known to be targeted by a blue-green algae neurotoxin.”
Blue-green algae is found in inland waterways and poses a health risk to people, domestic animals and stock that come into contact with the toxic algal blooms.
The research team at Mater Research and University of Queensland made the discovery in collaboration with Professor George Mellick at Griffith University and colleagues from New South Wales and New Zealand.
Their findings are the culmination of more than a decade of scientific effort.
Neurotoxins released by blue-green algae reduce activity of the gene identified in the study.
Researchers predict this will lead to higher oxidative stress levels in nerve cells associated with Parkinson’s disease, which can lead to cell death.
Dr Gratten said that while the study does not provide a direct link with Parkinson’s, blue-green algae had previously been associated with other neurodegenerative diseases such as motor neurone disease.
“This gives us confidence that we’re moving in the right direction towards understanding the environmental causes of Parkinson’s disease,” Dr Gratten said.
UQ geneticist Professor Peter Visscher, who co-led the study, said Parkinson’s disease affects 1 in 100 people over 60-years-old and that figure is projected to double by 2040 as the population ages.
“This disease destroys lives and devastates families, so we’re determined to unlock the mystery behind Parkinson’s,” Professor Visscher said.
“More work is needed to confirm our findings, and to explore other possible explanations for the link between this gene and Parkinson’s disease, such as pesticides.”
Mater Research Director of Biomedical Research Professor Allison Pettit said Dr Gratten brings important expertise to Mater Research’s capacity to discover modifiable contributors to common diseases that have complex genomic causes.
“Environmental factors are a common trigger of disease in people who have underlying genomic risks and linking the trigger to the risk is a significant research challenge,” she said.
“Dr Gratten and his colleagues were able to mine through a complex ‘big data’ collection and discover a modifiable potential trigger of Parkinson’s disease.
This is important research progress as eliminating environmental triggers will be a more easily navigated pathway to prevention/treatment in these complex diseases.”
The research is a collaboration between researchers from the Brain and Mind Centre, University of Sydney, University of Otago, New Zealand Brain Research Institute and the University of Canterbury, New Zealand.
The article was published in the high profile journal Nature Communications, thank you to the team at University of Queensland for the article.
07 3163 1524
07 3163 6142
Mater continues to work as part of the broader health network in support of Public Health efforts to contain, treat and manage COVID-19.
March 29 2020 marks an important milestone for the Speaking With Good Judgement (SWGJ) Program, being two years to the day since it was launched across Mater.
Mater Centre for Neurosciences has partnered with Epilepsy Queensland to provide a continuum of care for patients by helping them access essential support services in ...
March 21st is World Down Syndrome Day, where we celebrate the lives and achievements of people with Down Syndrome, creating a global voice, advocating for their ...